Parameters to improve the specificity of the prostate-specific antigen: Early detection of prostate cancer;Parameter zur verbesserung der spezifität des prostataspezifischen antigens: Früherkennung des prostatakarzinoms

Urologe - Ausgabe A

Volumn 50, Issue 9, 2011, Pages 1095-1100

  Borgermann C ^a,d   Kliner, S ^a,d   Swoboda, A ^b   Luboldt, H J ^c   Rubben H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Praxis für Urologie   (Germany)

^c Praxisklinik für Urologie ^*  (Germany)

^d Krankenhaus Duren gem GmbH   (Germany)

Author keywords

Early detection; Palpation findings; Probability of cancer; Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSTATE BIOPSY; PROSTATE CANCER; PUNCH BIOPSY; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; EARLY DIAGNOSIS; ENDOSONOGRAPHY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; ORGAN SIZE; PALPATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY IMPROVEMENT; RISK FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 80755138399     PISSN: 03402592     EISSN: 14330563     Source Type: Journal    
DOI: 10.1007/s00120-011-2577-8     Document Type: Article

References (29)

1. Andriole GL, Crawford ED, Grubb RL 3rd et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310-1319
2. Bazinet M, Karakiewicz PI, Aprikian AG et al (1996) Reassessment of nonplanimetric transrectal ultrasound prostate volume estimates. Urology 47:857-862 (Pubitemid 26198912)
3. Blanc M, Sacrini A, Avogadro A et al (1998) Prostatic volume: suprapubic versus transrectal ultrasonography in the control of benign prostatic hyperplasia. Radiol Med 95:182-187 (Pubitemid 128522737)
4. Borgermann C, Swoboda A, Luboldt HJ et al (2009) Thef/t-PSA ratio in diagnosis of in-patients and out-patients: a unitary cutoff value is not useful! World J Urol 27:581-585
5. Catalona WJ, Richie JP, Dekernion JB et al (1994) Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 152:2031-2036 (Pubitemid 24354721)
6. Catalona WJ, Smith DS, Ornstein DK (1997) Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 277:1452-1455 (Pubitemid 27208887)
7. Collins GN, Raab GM, Hehir M et al (1995) Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume. Ultrasound Med Biol 21:1101-1105
8. Crawford ED, Leewansangtong S, Goktas S et al (1999) Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values. Prostate 38:296-302 (Pubitemid 29119795)
9. Delong ER, Delong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics 44:837-845
10. Deras IL, Aubin SM, Blase A et al (2008) PCA3: a molecular urine assay for predicting prostate biopsy outcome. J Urol 179:1587-1592
11. Djavan B, Zlotta A, Remzi M et al (2000) Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 163:1144-1149 (Pubitemid 30169380)
12. Hoedemaeker RF, Rietbergen JB, Kranse R et al (2000) Histopathological prostate cancer characteristics at radical prostatectomy after population based screening. J Urol 164:411-415 (Pubitemid 30481938)
13. Luboldt H, Rubben H (2000) PSA-based early detection of prostate cancer. Urologe A 39:22-26 (Pubitemid 30163152)
14. Luboldt HJ, Altwein JE, Bichler KH et al (1999) Early recognition of prostate carcinoma. Initial results of a prospective multicenter study in Germany. Project Group for Early Detection DGU-BDU Laboratory diagnosis Professional Circle. Urologe A 38:114-123 (Pubitemid 29155740)
15. Luboldt HJ, Bex A, Swoboda A et al (2001) Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff. Eur Urol 39:131-137 (Pubitemid 32171178)
16. Luboldt HJ, Husing J, Altwein JE et al (2000) Early detection of prostatic carcinoma in urologic practice with digital rectal examination and prostate-specific antigen. Early Detection Project Group. Urologe A 39:330-333 (Pubitemid 30614961)
17. Matthews GJ, Motta J, Fracehia JA (1996) The accuracy of transrectal ultrasound prostatevolume estimation: clinical correlations. J Clin Ultrasound 24:501-505 (Pubitemid 26347786)
18. Mettlin C, Murphy GP, Lee F et al (1993) Characteristics of prostate cancers detected in a multimo-dality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project. Cancer 72:1701-1708 (Pubitemid 23249301)
19. Oberpenning F, Von Knobloch R, Sprute W et al (2008) DiaPat urine test for prostate cancer. Predictive value for results of transrectal ultrasound-guided prostate biopsies. Urologe A 47:735-739
20. Price CP, Allard J, Davies G et al (2001) Pre- and post-analytical factors that may influence use of serum prostate specific antigen and its isoforms in a screening programme for prostate cancer. Ann Clin Biochem 38:188-216 (Pubitemid 32430000)
21. Roehrborn CG, Sech S, Montoya J et al (2001) Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination. Urology 57:1087-1092 (Pubitemid 32455576)
22. Schmid HP, Riesen W, Prikler L (2004) Update on screening for prostate cancer with prostate-specific antigen. Crit Rev Oncol Hematol 50:71-78 (Pubitemid 38501618)
23. Schroder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320-1328
24. Sech S, Montoya J, Girman CJ et al (2001) Interexaminer reliability of transrectal ultrasound for estimating prostatevolume. J Urol 166:125-129 (Pubitemid 32565360)
25. Thompson IM, Goodman PJ, Tangen CM et al (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349: 215-224 (Pubitemid 36859473)
26. Tong S, Cardinal HN, Mcloughlin RF et al (1998) Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. Ultrasound Med Biol 24:673-681 (Pubitemid 28285203)
27. Van Der Cruijsen-Koeter IW, Wildhagen MF, De Koning HJ et al (2001) The value of current diagnostic tests in prostate cancer screening. BJU Int 88:458-466 (Pubitemid 34203479)
28. Virtanen A, Gomari M, Kranse R et al (1999) Estimation of prostate cancer probability by logistic regression: free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables. Clin Chem 45:987-994 (Pubitemid 29340535)
29. Wittke S, Schiffer E, Bauer HW (2007) Capillary electrophoresis coupled to mass spectrometry for proteome analysis. An innovative diagnostic method for prostate and bladder cancer. Urologe A 46:733-739 (Pubitemid 47047746)